Jones P M, O'Halloran D J, Ghatei M A, Domin J, Bloom S R
Department of Medicine, Royal Postgraduate Medical School, Hammersmith Hospital, London.
J Endocrinol. 1990 Dec;127(3):437-44. doi: 10.1677/joe.0.1270437.
Neuropeptide Y (NPY), neurotensin (NT), substance P (SP) and vasoactive intestinal peptide (VIP) are four structurally unrelated neuroendocrine peptides which affect anterior pituitary function. All four peptides appear to be locally synthesized in the anterior pituitary gland and have been shown to be regulated by thyroid and/or sex hormone status. We show here that NT, SP and VIP but not NPY are influenced by adrenal hormone status in the male rat pituitary gland. Adrenalectomy increased the content of VIP (35.4 +/- 4.0 (S.E.M.) vs control 11.9 +/- 1.1 pmol/g wet weight) but decreased that of SP (18.8 +/- 2.3 vs control 36.7 +/- 3.5 pmol/g wet weight). Adrenalectomy combined with castration decreased the content of SP (14.6 +/- 3.5 vs control 36.7 +/- 3.9 pmol/g wet weight) but had no effect on VIP content. Treatment with dexamethasone produced significant decreases in NT, SP and VIP contents (17.8 +/- 2.3 vs control 32.6 +/- 3.4 pmol/g wet weight, 5.5 +/- 0.9 vs control 36.7 +/- 3.9 pmol/g wet weight and 4.2 +/- 0.6 vs control 11.9 +/- 1.1 pmol/g wet weight respectively). The changes in pituitary peptide contents occurred in parallel with changes in mRNA levels, suggesting that alterations in glucocorticoid hormone status can alter the synthesis of these peptides. These results, together with the known effects of these neuroendocrine peptides suggest possible functions for locally produced SP and VIP in regulating the secretion of adrenocorticotrophin and/or other pro-opiomelanocortin-derived peptides.(ABSTRACT TRUNCATED AT 250 WORDS)
神经肽Y(NPY)、神经降压素(NT)、P物质(SP)和血管活性肠肽(VIP)是四种结构不相关的神经内分泌肽,它们会影响垂体前叶功能。这四种肽似乎都在垂体前叶局部合成,并且已被证明受甲状腺和/或性激素状态的调节。我们在此表明,在雄性大鼠垂体中,NT、SP和VIP受肾上腺激素状态的影响,而NPY不受影响。肾上腺切除增加了VIP的含量(35.4±4.0(标准误)对对照组11.9±1.1皮摩尔/克湿重),但降低了SP的含量(18.8±2.3对对照组36.7±3.5皮摩尔/克湿重)。肾上腺切除联合去势降低了SP的含量(14.6±3.5对对照组36.7±3.9皮摩尔/克湿重),但对VIP含量没有影响。地塞米松治疗使NT、SP和VIP的含量显著降低(分别为17.8±2.3对对照组32.6±3.4皮摩尔/克湿重、5.5±0.9对对照组36.7±3.9皮摩尔/克湿重和4.2±0.6对对照组11.9±1.1皮摩尔/克湿重)。垂体肽含量的变化与mRNA水平的变化平行,表明糖皮质激素状态的改变可改变这些肽的合成。这些结果,连同这些神经内分泌肽的已知作用,提示局部产生的SP和VIP在调节促肾上腺皮质激素和/或其他源自阿片黑素皮质素原的肽的分泌中可能具有的功能。(摘要截短于250字)